Biosense Webster – Health Economics & Outcomes Research

AF Burden of Disease and Treatment 

As a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, Biosense Webster, Inc. is committed to patient advocacy and raising awareness of atrial fibrillation and its available treatment options.

Biosense Webster – Health Economics & Outcomes Research

Atrial Fibrillation Burden of Disease Report

The AF Burden of Disease Report outlines the growing burden of AF on patients, caregivers and healthcare systems across Europe, emphasizing the scale and impact of the disease.

Atrial Fibrillation Burden of Disease Report

Atrial Fibrillation Management Report

The Atrial Fibrillation Management Report details current guideline-recommended treatment options for AF as well as their long-term impact on clinical, patient and economic outcomes, aiming to support healthcare professionals (HCPs) when making treatment decisions.

Atrial Fibrillation Management Report

Burden of AF

Full Report: The Burden of Atrial Fibrillation

Full Report: The Burden of Atrial Fibrillation

The Burden of Atrial Fibrillation: Executive Summary of 2018 Report

The Burden of Atrial Fibrillation: Executive Summary of 2018 Report

The Burden of Atrial Fibrillation: infographic

The Burden of Atrial Fibrillation: infographic

Infographic: The New Millennium Epidemic of Atrial Fibrillation

Infographic: The New Millennium Epidemic of Atrial Fibrillation

Management of AF

Atrial Fibrillation Management: 2019 Full Report

Atrial Fibrillation Management: 2019 Full Report

Atrial Fibrillation Management: 2019 Executive Summary

Atrial Fibrillation Management: 2019 Executive Summary

Atrial Fibrillation Management: Infographic

Atrial Fibrillation Management: Infographic

139424-200507